Quantifying EU Medicine Access Challenges

By Rene Pretorius

June 6, 2025

Introduction While EU medicine access challenges are a widely acknowledged reality, the 2024 EFPIA Patients W.A.I.T. Indicator study and Charles River Associates report quantify these hurdles, revealing a shared bu...
Revitalizing Innovation: The Impact of UK Medicine Payment Rates
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
Global Drug Price Gaps Demand Better Drug Pricing Analysis
NICE HealthTech Reforms: Accelerating Digital Innovation in NHS and Global He...
BioNTech BMS Collaboration: Pioneering Advances in Solid Tumor Treatment with...
Pluvicto Prostate Cancer Trial: Phase III Results
Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share
Tolebrutinib MS Analysis: Evaluating Economic Impact in SPMS
Allopurinol Designated an Orphan Drug for Marfan Syndrome
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...
HPV-Related Cancer Trends in South Africa 2011-2021